IBA (Ion Beam Applications S.A.), the global high-tech leader in next generation radiation therapy and diagnostics for the treatment of cancer, is pleased to announce that today 60 radiation therapy leaders travelled to Belgium to discover the first Proteus®ONE in factory.

Out of a range of mathematical methods for managing pulmonary nodules with FDG PET/CT, one quantitative CT technique takes the lead--dynamic area-detector CT analyzed using the dual-input maximum slope method, according to a study published May 22 in the American Journal of Roentgenology.

Many studies have maintained that the most advanced SPECT cameras can significantly reduce patient dose, but what about medical staff? A new protocol of myocardial perfusion SPECT imaging combines state-of-the-art detector technology, image reconstruction and stress-only imaging, all precipitating an up to 60 percent drop in radiation exposure to healthcare workers, according to a study published May 30 in the Journal of Nuclear Medicine.

UltraSPECT, a leading provider of nuclear medicine (NM) image reconstruction technology that reduces radiopharmaceutical dose and acquisition time, announces today the installation of its proprietary Wide Beam Reconstruction (WBR™) software at nearly ten healthcare facilities.

Molecular imaging has been in a growth phase since 2010, spurred by emerging markets and demand for hybrid and other cutting edge scanner and biomarker technologies, according to a market report profiling the most recent developments in molecular imaging published in April by UK-based Espicom Business Intelligence.

A team of radiologists and neurologists at University Hospitals Case Medical Center in Cleveland are enrolling patients with suspected early-stage Alzheimer’s disease in a study designed to determine if Amyvid can identify amyloid plaques via PET or MRI. Read more about the research by clicking the link below.

While healthcare reform has been slowly evolving as a result of many acts of Congress during the past decade, it is the Affordable Care Act of 2010 (ACA), that is driving major changes in healthcare coverage, the economics of the medical industry and quality of care. The latter is being carried by a series of reporting and incentive programs that have a direct impact on the practice of nuclear medicine and molecular imaging, according to a review published March 1 in the Journal of Nuclear Medicine Technology.

Cerebral blood flow (CBF) is an emerging indication of Alzheimer’s pathology and dynamic susceptibility contrast (DSC) MRI may be an ideal modality to track CBF in high-risk patients with mild cognitive impairment, as well as those already diagnosed with the disease, according to a study published in the June issue of Academic Radiology.